Prime Medicine, Inc.·4

Mar 4, 4:15 PM ET

Gottesdiener Keith Michael 4

4 · Prime Medicine, Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Gottesdiener Keith Michael
DirectorSee Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-28+500,000500,000 total
    Exercise: $2.52Exp: 2035-02-28Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 28, 2025, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wk-form4_1741122898.xmlPrimary

    FORM 4